CA2579292A1 - Cellules souches hematopoietiques de lignees negatives isolees et methodes de traitement associees - Google Patents

Cellules souches hematopoietiques de lignees negatives isolees et methodes de traitement associees Download PDF

Info

Publication number: CA2579292A1
Authority: CA; Canada
Prior art keywords: cells; hsc; hematopoietic stem; isolated; retinal
Prior art date: 2004-09-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002579292A

Other languages

English (en)

Inventor

Martin Friedlander

Atsushi Otani

Karen Da Silva

Stacey Moreno (Hanekamp)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Scripps Research Institute

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-03

Filing date

2005-09-02

Publication date

2006-03-23

2004-09-03 Priority claimed from US10/933,634 external-priority patent/US20050129665A1/en

2005-09-02 Application filed by Individual filed Critical Individual

2005-09-02 Priority claimed from PCT/US2005/031304 external-priority patent/WO2006031467A2/fr

2006-03-23 Publication of CA2579292A1 publication Critical patent/CA2579292A1/fr

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA002579292A 2004-09-03 2005-09-02 Cellules souches hematopoietiques de lignees negatives isolees et methodes de traitement associees Abandoned CA2579292A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/933,634		2004-09-03
US10/933,634 US20050129665A1 (en)	2002-07-25	2004-09-03	Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
PCT/US2005/031304 WO2006031467A2 (fr)	2002-07-25	2005-09-02	Cellules souches hematopoietiques de lignees negatives isolees et methodes de traitement associees

Publications (1)

Publication Number	Publication Date
CA2579292A1 true CA2579292A1 (fr)	2006-03-23

Family

ID=37903853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002579292A Abandoned CA2579292A1 (fr)	2004-09-03	2005-09-02	Cellules souches hematopoietiques de lignees negatives isolees et methodes de traitement associees

Country Status (8)

Country	Link
EP (1)	EP1802199A4 (fr)
JP (1)	JP2008512376A (fr)
KR (1)	KR101309500B1 (fr)
CN (1)	CN101052305B (fr)
AU (1)	AU2005285246B2 (fr)
CA (1)	CA2579292A1 (fr)
MX (1)	MX2007002639A (fr)
ZA (1)	ZA200702607B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2554662A1 (fr) *	2011-08-05	2013-02-06	M Maria Pia Cosma	Procédés pour le traitement de maladies rétiniennes dégénératives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5928638A (en) *	1996-06-17	1999-07-27	Systemix, Inc.	Methods for gene transfer
US7219016B2 (en) *	2001-04-20	2007-05-15	Yale University	Systems and methods for automated analysis of cells and tissues
US6939378B2 (en) *	2001-06-01	2005-09-06	The Board Of Trustees Of The Leland Stanford Junior University	Microfabricated tissue as a substrate for pigment epithelium transplantation
ATE378056T1 (de) *	2001-08-10	2007-11-15	Imclone Systems Inc	Medizinische verwendung von stammzellen, die vegfr-1 exprimieren
CA2465001A1 (fr) *	2001-10-30	2003-05-08	Daiichi Pharmaceutical Co., Ltd.	Procede permettant d'augmenter les cellules hematopoietiques souches
CN1194086C (zh) *	2002-02-01	2005-03-23	北京科宇联合干细胞生物技术有限公司	一种神经干细胞制剂的制备方法
BR0312920A (pt) *	2002-07-25	2007-07-10	Scripps Research Inst	células tronco hematopoéticas e métodos de tratamento de doenças oculares neovasculares com as mesmas

2005
- 2005-09-02 EP EP05814042A patent/EP1802199A4/fr not_active Withdrawn
- 2005-09-02 CA CA002579292A patent/CA2579292A1/fr not_active Abandoned
- 2005-09-02 CN CN2005800379820A patent/CN101052305B/zh not_active Expired - Fee Related
- 2005-09-02 MX MX2007002639A patent/MX2007002639A/es active IP Right Grant
- 2005-09-02 AU AU2005285246A patent/AU2005285246B2/en not_active Ceased
- 2005-09-02 KR KR1020077007667A patent/KR101309500B1/ko not_active Expired - Fee Related
- 2005-09-02 JP JP2007530394A patent/JP2008512376A/ja active Pending
2007
- 2007-03-28 ZA ZA200702607A patent/ZA200702607B/xx unknown

Also Published As

Publication number	Publication date
KR20070104512A (ko)	2007-10-26
CN101052305B (zh)	2012-10-10
AU2005285246A1 (en)	2006-03-23
MX2007002639A (es)	2007-08-06
JP2008512376A (ja)	2008-04-24
EP1802199A4 (fr)	2008-08-27
EP1802199A2 (fr)	2007-07-04
ZA200702607B (en)	2008-08-27
KR101309500B1 (ko)	2013-09-24
AU2005285246B2 (en)	2011-07-21
CN101052305A (zh)	2007-10-10

Publication	Publication Date	Title
US7838290B2 (en)	2010-11-23	Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
WO2004098499A2 (fr)	2004-11-18	Cellules souches hematopoietiques et methodes de traitement de maladies oculaires neovasculaires utilisant ces cellules souches
AU2007322084B2 (en)	2013-06-20	Isolated myeloid-like cell populations and methods of treatment therewith
US8900567B2 (en)	2014-12-02	Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
EP1935976B1 (fr)	2012-02-15	Cellules myeloides transfectées pour le traitement de rétinopathie de prématurité et maladies rétinopathiques associées
US20110201108A1 (en)	2011-08-18	Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
US20100303768A1 (en)	2010-12-02	Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
AU2005239702B2 (en)	2010-03-04	Hematopoietic stem cells and methods of treatment of neovascular diseases therewith
WO2006031467A2 (fr)	2006-03-23	Cellules souches hematopoietiques de lignees negatives isolees et methodes de traitement associees
AU2005285246B2 (en)	2011-07-21	Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
US20060104962A1 (en)	2006-05-18	Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Legal Events

Date	Code	Title	Description
2010-08-20	EEER	Examination request
2017-10-05	FZDE	Discontinued	Effective date: 20170824